Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-09 Purchase |
2021-03-09 6:59 pm |
Evofem Biosciences Inc. | EVFM | PELLETIER SAUNDRA L Chief Executive Officer |
45,249 | $2.28 | $103,168 | 906,137 (Direct) |
View |
| 2020-11-17 Purchase |
2020-11-18 5:22 pm |
Evofem Biosciences Inc. | EVFM | File Justin J. Chief Financial Officer |
7,760 | $2.17 | $16,839 | 258,168 (Direct) |
View |
| 2020-11-17 Purchase |
2020-11-18 5:14 pm |
Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary |
9,090 | $2.2 | $19,998 | 143,542 (Direct) |
View |
| 2020-09-10 Purchase |
2020-09-11 5:20 pm |
Evofem Biosciences Inc. | EVFM | Barrans Russell Chief Commercial Officer |
4,000 | $2.2375 | $8,950 | 279,331 (Indirect Direct) |
View |
| 2020-09-08 Sale |
2020-09-10 8:04 pm |
Evofem Biosciences Inc. | EVFM | PELLETIER SAUNDRA L Chief Executive Officer |
122,500 | $3.26 | $399,350 | 360,888 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-12 Option Award |
2021-05-13 4:13 pm |
N/A 2031-05-12 |
Evofem Biosciences Inc. | EVFM | Hall William Walmsley Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-03 8:05 pm |
N/A 2031-02-03 |
Evofem Biosciences Inc. | EVFM | PELLETIER SAUNDRA L Chief Executive Officer |
1,200,000 | $0 | 1,560,888 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-03 8:02 pm |
N/A 2031-02-03 |
Evofem Biosciences Inc. | EVFM | Barrans Russell Chief Commercial Officer |
350,000 | $0 | 632,131 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-03 8:00 pm |
N/A 2031-02-03 |
Evofem Biosciences Inc. | EVFM | File Justin J. Chief Financial Officer |
350,000 | $0 | 608,168 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-03 7:57 pm |
N/A 2031-02-03 |
Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary |
350,000 | $0 | 493,542 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-03 7:54 pm |
N/A 2031-02-03 |
Evofem Biosciences Inc. | EVFM | Culwell Kelly Chief Medical Officer |
350,000 | $0 | 465,451 (Direct) |
View |